ALB and neoplasm: The formation of stable covalent bonds between the drugs and HSA contributes to the systemic delivery of the nanoparticle, subsequently triggering trace lysis and release of bioactive Pt (IV), Ce6 and CAT in the acidic tumor microenvironment (TME).